Holen Sie sich die Stockscreener-App
3.26
10.14%
0.30
Handel nachbörslich:
3.29
0.03
+0.92%
Schlusskurs vom Vortag:
$2.96
Offen:
$2.84
24-Stunden-Volumen:
7.78M
Relative Volume:
0.60
Marktkapitalisierung:
$440.08M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-35.47M
KGV:
-5.7193
EPS:
-0.57
Netto-Cashflow:
$-124.27M
1W Leistung:
+25.38%
1M Leistung:
+50.93%
6M Leistung:
+538.09%
1J Leistung:
+88.44%
1-Tages-Spanne:
$2.77
$3.41
1-Wochen-Bereich:
$2.62
$3.41
52-Wochen-Spanne:
$0.4603
$7.13
Prokidney Corp Stock (PROK) Company Profile
Firmenname
Prokidney Corp
Sektor
Branche
Telefon
336-999-7028
Adresse
2000 FRONTIS PLAZA BLVD., WINSTON-SALEM
Vergleichen Sie PROK mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PROK
Prokidney Corp
|
3.26 | 399.58M | 0 | -35.47M | -124.27M | -0.57 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Prokidney Corp Stock (PROK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-09-30 | Eingeleitet | JP Morgan | Neutral |
| 2024-09-10 | Eingeleitet | Guggenheim | Buy |
| 2024-03-07 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2024-01-02 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-07-25 | Eingeleitet | BTIG Research | Buy |
| 2022-12-21 | Eingeleitet | Jefferies | Buy |
| 2022-11-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-10-18 | Eingeleitet | UBS | Buy |
| 2022-10-14 | Eingeleitet | Citigroup | Buy |
| 2022-09-23 | Eingeleitet | BofA Securities | Buy |
| 2022-09-02 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
Prokidney Corp Aktie (PROK) Neueste Nachrichten
ProKidney (NASDAQ:PROK) Shares Gap DownWhat's Next? - MarketBeat
Will ASN Spotlight On REGEN-007 Propel ProKidney Toward Accelerated Approval? - RTTNews
Using AI based signals to follow ProKidney Corp.Quarterly Portfolio Report & Advanced Swing Trade Entry Plans - newser.com
What institutional flow reveals about ProKidney Corp.Layoff News & Smart Allocation Stock Reports - newser.com
Smart tools for monitoring ProKidney Corp.’s price actionGap Up & Community Consensus Trade Alerts - newser.com
ProKidney Corp (PROK) Touts Reparencel Therapy for Growth - MSN
Will ProKidney Corp. see short term momentumJuly 2025 Trade Ideas & Safe Entry Point Alerts - newser.com
Is it time to cut losses on ProKidney Corp.2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Why ProKidney Corp. stock appeals to dividend seekers2025 Top Gainers & Capital Efficient Trade Techniques - newser.com
ProKidney (NASDAQ:PROK) Trading 8.1% HigherShould You Buy? - MarketBeat
What drives ProKidney Corp stock priceTop Performing Stocks & Create Your Free Watchlist Instantly - earlytimes.in
Is ProKidney Corp a good long term investmentRisk Management Strategies & Low Cost Market Strategies - earlytimes.in
ProKidney Corp. (NASDAQ:PROK) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat
Layoff Watch: Is TBBB stock a top performer YTDGDP Growth & Weekly High Momentum Picks - khodrobank.com
Earnings Beat: Is ProKidney Corp impacted by rising ratesWeekly Gains Report & Stepwise Trade Execution Plans - khodrobank.com
Whale Trades: What are ProKidney Corp.’s recent SEC filings showingGlobal Markets & Verified Entry Point Detection - خودرو بانک
ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy - Seeking Alpha
ETF Watch: Why is ProKidney Corp stock going downJuly 2025 Review & Community Driven Trade Alerts - خودرو بانک
Risk Recap: Is FLNT’s ROIC above industry averageMarket Activity Summary & Free Expert Verified Stock Movement Alerts - khodrobank.com
Aug Movers: Will ProKidney Corp outperform tech stocks2025 Dividend Review & Fast Gain Stock Trading Tips - خودرو بانک
Market Overview: Is ProKidney Corp stock a top performer YTDTrade Ideas & Expert Approved Momentum Ideas - خودرو بانک
Earnings Recap: Will ProKidney Corp benefit from government policy2025 Geopolitical Influence & Technical Pattern Recognition Alerts - khodrobank.com
Pharma News: Can ProKidney Corp continue delivering strong returns2025 Fundamental Recap & Fast Entry High Yield Stock Tips - khodrobank.com
Risk Report: Does ProKidney Corp meet Warren Buffetts criteriaAnalyst Downgrade & Free Verified High Yield Trade Plans - khodrobank.com
Market Rankings: Why is ProKidney Corp. stock going upPortfolio Value Report & Free Verified High Yield Trade Plans - خودرو بانک
ProKidney (NASDAQ:PROK) Shares Down 6.9%Should You Sell? - MarketBeat
Growth Value: Is Intelligent Bio Solutions Inc part of any major index2025 Fundamental Recap & Accurate Technical Buy Alerts - خودرو بانک
Meme Stocks: Is SAP SE ADRhedged forming a breakout patternTreasury Yields & Free Long-Term Investment Growth Plans - خودرو بانک
Block Trades: Is ProKidney Corp stock undervalued right nowJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Pullback Watch: Can ProKidney Corp weather a recessionJuly 2025 Rallies & Risk Controlled Stock Alerts - خودرو بانک
ProKidney (NASDAQ:PROK) Stock Price Up 21.1%Still a Buy? - MarketBeat
Block Trades: Will ProKidney Corp benefit from government policyJuly 2025 Outlook & Capital Efficiency Focused Strategies - خودرو بانک
Finanzdaten der Prokidney Corp-Aktie (PROK)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
4.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):